Pivotal Clinical ApS

CVR 40343040 · Private limited company (ApS) · Active · Low risk

Pivotal Clinical ApS is a Private limited company (ApS), founded on , based in Herlev. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 7 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 50k and a net result of DKK -82. CEO: Ibrahim Naman Farr Juri.

Bankruptcy risk for Pivotal Clinical ApS

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 60% of active Danish companies

Lowest riskHighest risk

Increases the risk

Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×
Published annual reports5–10 · bankruptcy rate 6.3%0.72×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
40343040
Status
Active
Company type
Private limited company (ApS)
Founded
(7 years)
Address
c/o Aspia Denmark A/S, Herlev Hovedgade 195A
2730 Herlev
Municipality
Herlev
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 50k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 7
Missing annual reportNo
Negative equityNo
Equity ratio100.0%
Current ratio–
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address80
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -75DKK -25
Net profitDKK -82DKK -32
EquityDKK 50kDKK 50k
Total assetsDKK 50kDKK 50k
CashDKK 50k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202554
1 Jan 2024 – 31 Dec 2024134
1 Jan 2023 – 31 Dec 202373
1 Jan 2022 – 31 Dec 202267
1 Jan 2021 – 31 Dec 2021143
1 Jan 2020 – 31 Dec 2020141
6 Mar 2019 – 31 Dec 2019183

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOIbrahim Naman Farr JuriCurrent
Owner (100%)Pivotal S.L.Current
FounderPivotal S.L.Current

Address history (1 moves)

c/o Aspia Denmark A/S, Herlev Hovedgade 195A, 2730 Herlev
c/o Accountor Denmark A/S, Herlev Hovedgade 195A, 2730 Herlev

Other companies at the same address

Similar companies in Herlev

Questions and answers about Pivotal Clinical ApS

Has Pivotal Clinical ApS gone bankrupt?

No, Pivotal Clinical ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Pivotal Clinical ApS?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of Pivotal Clinical ApS?

Ibrahim Naman Farr Juri is the CEO of Pivotal Clinical ApS.

When was Pivotal Clinical ApS founded?

Pivotal Clinical ApS was founded on 6 March 2019.

What is the equity of Pivotal Clinical ApS?

Equity was DKK 50k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.